Misunderstandings regarding clinical cross-over trials

Statistics in Medicine

Volumn 24, Issue 23, 2005, Pages 3675-3678

  Senn, Stephen ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ANALYTICAL ERROR; ASTHMA; CLINICAL STUDY; CLINICAL TRIAL; EXPERIMENTAL DESIGN; HUMAN; LETTER; PROCESS MODEL; RANDOMIZATION; SAMPLING; STATISTICAL ANALYSIS; STATISTICAL MODEL;

BIOMETRY; CLINICAL TRIALS; CROSS-OVER STUDIES; HUMANS; MODELS, STATISTICAL;

EID: 28244495068     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.2155     Document Type: Letter

References (14)

1. John JA, Russell KG, Whitaker D. CrossOver: an algorithm for the construction of efficient cross-over designs. Statistics in Medicine 2004; 23:2645-2658.
2. Jones B, Donev AN. Modelling and design of cross-over trials. Statistics in Medicine 1996; 15:1435-1446.
3. Senn SJ. Cross-over Trials in Clinical Research. Wiley: Chichester, 2002.
4. Senn SJ. The AB/BA crossover: past, present and future? Statistical Methods in Medical Research 1994; 3: 303-324.
5. Palmqvist M, Balder B, Lowhagen O, Melander B, Svedmyr N, Wahlander L. Late asthmatic reaction decreased after pretreatment with salbutamol and formoterol, a New Long-Acting Beta-2-Agonist. Journal of Allergy and Clinical Immunology 1992; 89:844-849.
6. Grieve AP, Senn S. A comment on interim analyses in crossover trials. Biometrics 1996; 52:1515-1520.
7. Senn SJ. A personal view of some controversies in allocating treatment to patients in clinical trials [see comments]. Statistics in Medicine 1995; 14:2661-2674.
8. Senn SJ. Statistical Issues in Drug Development. Wiley: Chichester, 1997.
9. Holford NH, Peace KE. Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine. Proceedings of National Academy of Science U.S.A. 1992; 89: 11471-11475.
10. Fleiss JL. Letter to the editor. Biometrics 1986; 42:449-450.
11. Senn SJ. Is the 'simple carry-over' model useful? [published erratum appears in Statistics in Medicine 1992 Sep 15; 11(12):1619]. Statistics in Medicine 1992; 11:715-726.
12. Senn SJ, Lambrou D. Robust and realistic approaches to carry-over. Statistics in Medicine 1998; 17:2849-2864.
13. Holford NH, Sheiner LB. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clinical Pharmacokinetics 1981; 6:429-453.
14. Sheiner LB, Hashimoto Y, Beal SL. A simulation study comparing designs for dose-ranging. Statistics in Medicine 1991; 9:1287-1302.